Skip to content
MenoGeniX, Inc logo — MenoGeniX, Inc is a biotechnology company based out of Biosc...

MenoGeniX, Inc

MenoGeniX, Inc is a biotechnology company based out of Bioscience Park Center 12635 East Montview Boulevard Suite 100, A

Founded 2010 United States Aurora, United States 1 employees Grant Total: $1.11M Biotechnology, Medical Devices

General Information

Company Name MenoGeniX, Inc
Founded Year 2010
Location United States Aurora, United States
Founders / Decision Makers
Team member
Employees 1
Industries Biotechnology, Medical Devices
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with MenoGeniX, Inc. To contact MenoGeniX, Inc, visit menogenix.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does MenoGeniX, Inc compare?

A PDF of MenoGeniX, Inc and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting MenoGeniX, Inc soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About MenoGeniX, Inc

MenoGeniX is a biotechnology company based out of Bioscience Park Center 12635 East Montview Boulevard Suite 100, A. Founded in 2010, MenoGeniX is a privately-held, clinical stage biopharmaceutical company dedicated to researching and developing a novel potential treatment for women suffering from hot flashes and related vasomotor symptoms of menopause. Specializing in the Biotechnology industry, the company is headquartered in the United States. Their last investment, a grant investment at 03 May 2018, came from the National Institutes of Health.

Business keywords: clinical stage, biopharmaceutical, women's health, menopause, hot flashes, vasomotor symptoms, development, treatment, private company, innovation, bioscience, therapeutics

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Grant Undisclosed 1
National Institutes of Health
03 May 2018
Seed Round $200.00K -
16 Sep 2016
Seed Round $405.00K -
14 Aug 2014
Seed Round $500.00K -
31 Jul 2012

MenoGeniX, Inc Alternatives & Competitors

View All Alternatives
MenoGeniX, Inc vs

TARGETING DIFFICULT TO TREAT CANCERS

Post-IPO Equity
7 employees
Biotechnology, Medical Devices
MenoGeniX, Inc vs

Madrigal is focused on delivering novel therapeutics for MASH, a serious liver disease.

IPO
1129 employees
Biopharma, Biotechnology
MenoGeniX, Inc vs

Pioneering advanced immunotherapies to amplify cancer treatment options and improve patient outcomes...

Series C
11-50 employees
Biotechnology, Health and Wellness

FAQ About MenoGeniX, Inc

MenoGeniX, Inc is a biotechnology company based out of Bioscience Park Center 12635 East Montview Boulevard Suite 100, A
MenoGeniX, Inc was founded in 2010.
MenoGeniX, Inc is headquartered in Aurora, United States.
MenoGeniX, Inc operates in Biotechnology and Medical Devices. Its work centres on clinical stage, biopharmaceutical, women's health and menopause.
MenoGeniX, Inc has approximately 1 employees.
MenoGeniX, Inc has completed 4 funding rounds, raising a total of $1.11M. The latest funding stage is Grant.
Top alternatives and competitors to MenoGeniX, Inc include Rexahn Pharmaceuticals, Madrigal Pharmaceuticals, Checkmate Pharmaceuticals, Osteal Therapeutics, Cirius Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MenoGeniX, Inc and Rexahn Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for MenoGeniX, Inc, https://bouncewatch.com/company/menogenix, updated 28 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout